| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0039-6060(05)80102-3 |
| P698 | PubMed publication ID | 7491542 |
| P50 | author | Jeffrey A Norton | Q92191219 |
| Douglas L. Fraker | Q123195653 | ||
| H. Richard Alexander | Q123195986 | ||
| P2093 | author name string | R T Jensen | |
| I Lubensky | |||
| M P MacFarlane | |||
| P2860 | cites work | Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers | Q38370316 |
| Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. | Q40712327 | ||
| Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. | Q42497648 | ||
| Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome | Q43724851 | ||
| Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy | Q47424929 | ||
| Percutaneous Transhepatic Venous Sampling of Gastrin | Q57499848 | ||
| Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome | Q68084123 | ||
| The role of surgery in the Zollinger-Ellison syndrome | Q71724899 | ||
| Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study | Q72281843 | ||
| Resection of Gastrinomas | Q72563383 | ||
| MEN I pancreas: A histological and immunohistochemical study | Q72746929 | ||
| A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas | Q72860964 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| multiple endocrine neoplasia type 1 | Q3347154 | ||
| P304 | page(s) | 973-9; discussion 979-80 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Surgery | Q15731526 |
| P1476 | title | Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1 | |
| P478 | volume | 118 |
| Q33879692 | A case of multiple endocrine neoplasia type 1 with primary liver gastrinoma |
| Q73152293 | A personal experience with pancreatic and duodenal neuroendocrine tumors |
| Q36085109 | Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome |
| Q73042506 | Author reply |
| Q37056120 | Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors |
| Q46234692 | Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome |
| Q35934399 | Current concepts in functioning endocrine tumors of the pancreas |
| Q36988013 | Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization. |
| Q33719585 | Diagnosis and treatment of ECL cell tumors |
| Q51530644 | Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome? |
| Q24603675 | ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes |
| Q26747174 | Endocrine neoplasms in familial syndromes of hyperparathyroidism |
| Q47741330 | Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis |
| Q34678156 | Gastrinoma |
| Q77292865 | Gastrinoma: advances in localization and treatment |
| Q41098171 | Gastrointestinal endocrine cancers and nodal metastasis: biologic significance and therapeutic implications. |
| Q41439948 | Gastrointestinal endocrine tumours. Gastrinoma |
| Q28290833 | Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors |
| Q43066318 | Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies |
| Q89420663 | Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies |
| Q49820370 | Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract |
| Q24647838 | Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies |
| Q34074138 | Laparoscopic approach to adrenal and endocrine pancreatic tumors |
| Q26738541 | Management of gastric and duodenal neuroendocrine tumors |
| Q50975431 | Management of the Zollinger-Ellison syndrome in pregnancy. |
| Q73261772 | Metastatic Gastrinoma in MEN I Syndrome |
| Q36063577 | Multiple Endocrine Neoplasia: Genetics and Clinical Management |
| Q34924827 | Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance |
| Q81573105 | Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1 |
| Q79775342 | Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias |
| Q35065094 | Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection |
| Q36632665 | Pharmacotherapy of Zollinger-Ellison syndrome |
| Q46831174 | Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study |
| Q77917882 | Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE) |
| Q40845787 | Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome |
| Q37279937 | Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. |
| Q35922060 | Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome |
| Q80154242 | Surgery increases survival in patients with gastrinoma |
| Q34584654 | Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1. |
| Q40917858 | Surgical management of gastrointestinal endocrine tumours |
| Q37511722 | Surgical management of pancreatic endocrine tumors |
| Q34311295 | The surgical management of pancreatic neuroendocrine tumors |
| Q34524836 | The surgical management of pancreaticoduodenal tumours in multiple endocrine neoplasia type 1. |
| Q54638848 | Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy. |
| Q38956091 | Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies |
| Q33618319 | Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE) |
| Q34390574 | Zollinger-Ellison syndrome: classical considerations and current controversies. |
| Q38150165 | Zollinger-Ellison syndrome: recent advances and controversies |
| Q82974606 | [Current trend: endocrine tumors of the stomach, small bowel, colon and rectum] |
Search more.